Roux-en-Y Gastric Bypass Improved Insulin Resistance via Alteration of the Human Gut Microbiome and Alleviation of Endotoxemia

BACKGROUND: Obesity is a main contributing factor for the development of glucose intolerance and type 2 diabetes mellitus (T2D). Roux-en-Y gastric bypass (RYGB) is believed to be one of the most effective treatments to reduce body weight and improve glucose metabolism. In this study, we sought to ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Qiping, Wang, Qian, Zhong, Hui, Li, Dehai, Yu, Shuxing, Yang, Hengwen, Wang, Cunchuan, Yin, Zhinan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294027/
https://www.ncbi.nlm.nih.gov/pubmed/34337024
http://dx.doi.org/10.1155/2021/5554991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294027/
https://www.ncbi.nlm.nih.gov/pubmed/34337024
http://dx.doi.org/10.1155/2021/5554991

Ejemplares similares